Neurodevelopmental Treatment (NDT)

Positive effects for CP and adult neurological conditions; comparative superiority vs dose-matched alternatives not demonstrated.

Applicable in pediatric and adult neurological rehabilitation; broadly used in both peds and neuro settings.

Billed under therapeutic activities and neuro re-education codes; no NDT-specific code; standard commercial and Medicare coverage.

8-day basic course; significant cost (~$2,000+); advanced courses add further investment.

Frequently listed as required or preferred in pediatric and neuro PT/OT postings; strong institutional adoption.

Hands-on facilitation approach well-tolerated; neuro population engagement is complex.

Pediatric and stroke families occasionally pay cash for NDT-trained therapists, but most care is insurance-based.

Some brand recognition among parents of CP kids, but limited pricing power overall.

Recognizable legacy brand in peds/neuro; differentiates within those niches.

Hands-on, clinician-dependent model; doesn't scale across staff easily.

Modest direct recognition in pediatric communities; otherwise low.

Long, expensive multi-week course series; poor cost/time profile.

Increasingly viewed as dated; not weighted heavily in modern faculty hiring.

Limited contemporary publication output associated with the credential.

Still referenced in peds/neuro curricula, useful for historical and handling-skill content.

Evidence base is weak; systematic reviews show NDT is no better than alternatives.

Rarely required; programs prefer NCS or PCS.

Expensive and time-intensive relative to the academic recognition gained.